- Report
- March 2026
- 214 Pages
Global
From €4425EUR$4,900USD£3,792GBP
- Report
- September 2026
- 184 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- September 2026
- 182 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- September 2026
- 172 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- February 2026
- 250 Pages
Global
From €4055EUR$4,490USD£3,474GBP
- Report
- February 2026
- 250 Pages
Global
From €4055EUR$4,490USD£3,474GBP
- Report
- August 2026
- 148 Pages
Global
From €4290EUR$4,750USD£3,676GBP
- Report
- December 2025
- 473 Pages
Global
From €4334EUR$4,799USD£3,714GBP
- Report
- June 2026
- 120 Pages
Global
From €5374EUR$5,950USD£4,604GBP
- Report
- April 2026
- 120 Pages
Global
From €5374EUR$5,950USD£4,604GBP
- Report
- September 2026
- 182 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- September 2026
- 180 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- September 2026
- 182 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- September 2026
- 276 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- March 2026
- 250 Pages
Global
From €4055EUR$4,490USD£3,474GBP
- Report
- February 2026
- 250 Pages
Global
From €4055EUR$4,490USD£3,474GBP
- Report
- September 2026
- 184 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- July 2026
- 150 Pages
Global
From €3387EUR$3,750USD£2,902GBP
- Report
- May 2026
- 350 Pages
Global
From €4470EUR$4,949USD£3,830GBP
- Report
- October 2025
- 196 Pages
Global
From €4511EUR$4,995USD£3,865GBP

The Bio CMO market is a subset of the biopharmaceutical industry, which focuses on the production of biopharmaceuticals. Bio CMOs provide contract manufacturing services to biopharmaceutical companies, such as drug development, clinical trial materials, and commercial production. These services are typically tailored to the specific needs of the customer, and can include process development, analytical services, and quality control. Bio CMOs are also responsible for the production of biopharmaceuticals, including the manufacture of active pharmaceutical ingredients (APIs) and the formulation of finished dosage forms.
Bio CMOs are an important part of the biopharmaceutical industry, as they provide the necessary services to enable the development and production of biopharmaceuticals. Examples of companies in the Bio CMO market include Lonza, Boehringer Ingelheim, Catalent, and Patheon. Show Less Read more